JOHN CORSI: Open Payments
NPI 1689685042 · SMITHFIELD, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 98 payments from 18 companies in 2025. Trend: 2023 $2,540 · 2024 $1,761 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $431 |
| GlaxoSmithKline, LLC. | 17 | $269 |
| PFIZER INC. | 13 | $256 |
| Novo Nordisk Inc | 10 | $207 |
| ABBVIE INC. | 12 | $190 |
| Phathom Pharmaceuticals, Inc. | 7 | $112 |
| Verona Pharma, Inc. | 4 | $87 |
| Exact Sciences Corporation | 2 | $42 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
| Dexcom, Inc. | 2 | $37 |
Products named: TRELEGY ELLIPTA, BREZTRI, FARXIGA, ELIQUIS, NURTEC ODT, VRAYLAR, VOQUEZNA, Ohtuvayre.
Industry payments across RI — which companies pay providers there.
